|
|
|
Company
Name |
Short
Summary |
| Advanced
Biomedical Research |
Advanced
Biomedical Research, Inc. (ABR) is a full service
contract research organization. |
| Alere |
Alere is focused on combining diagnostics with health management services to help determine the best course of treatment. |
| BioWa |
BioWa is focused on research and development of fucose-free monoclonal antibodies that demonstrate increased antibody-dependent cellular cytotoxicity (ADCC). |
| Bristol-Myers
Squibb |
Bristol-Myers
Squibb is a leading diversified worldwide health
and personal care company whose principal businesses
are medicines, beauty care, nutritionals, and
medical devices. |
| Celator Pharmaceuticals |
Celator Pharmaceuticals is focused on the development of synergistic ratios of drugs to improve therapies to treat cancer. |
| Covance |
Covance
is one of the world's largest and most comprehensive
drug development services companies. |
| Derma
Sciences |
Derma
Sciences is a full-line wound management & skin
care products company. |
| Eleison Pharmaceuticals |
Eleison Pharmaceuticals is focused on the acquisition, development, and commercialization of clinical stage drug candidates for orphan indications. |
| Laurate Pharma |
Laureate Pharma is focused on providing contract development and cGMP manufacturing services for mammalian cell based monoclonal antibody and recombinant protein production. |
| Lexicon Pharmaceuticals |
Lexicon Pharmaceuticals is focused on the discovery and development of drug candidates identified using mouse gene knockouts. These drug candidates target a variety of diseases across several therapeutic areas. |
| Onconova Therapeutics |
Onconova Therapeutics is focused on the discovery and development of drugs for treating cancer and radiation injury. |
| PharmaNet Development Group |
PharmaNet Development Group is focused on providing drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies. |
| Pharmasset |
Pharmasset is focused on the research and development of drugs to treat patients with viral infections. |
| Ranbaxy
Pharmaceuticals |
Ranbaxy
Pharmaceuticals is involved in the production and
marketing of approved generic pharmaceuticals. |
| Soligenix |
Soligenix focused on the development of products to treat life-threatening side effects of cancer treatment, serious gastrointestinal diseases, and vaccines for selected bioterrorism agents. |
| VIA Pharmaceuticals |
VIA Pharmaceuticals is focused on the development of small-molecule drugs to treat cardiovascular and metabolic disease. |
